A QSAR Study on Novel Series of Carbonic Anhydrase Inhibitors hCA IX—Tumor-Associated (Hypoxia)

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|8|4|656-672

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.8, Iss.4, 2012-07, pp. : 656-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparative Molecular Field (CoMFA) Studies on Carbonic Anhydrase Inhibitor hCA IX-Tumor-Associated (Hypoxia)

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 9, 2011-11 ,pp. : 877-883

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore Modeling and 3D QSAR Studies of Novel Human Carbonic Anhydrase IX Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-11 ,pp. : 808-816

Bentham Science Publishers

Access to resources Recommend Favorite

Toward the Identification of Novel Carbonic Anhydrase XIV Inhibitors using 3D-QSAR Pharmacophore Model, Virtual Screening and Molecular Docking Study

By  

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 403-412

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors: CA IX selective inhibitors incorporating aromatic or heterocyclic sulfonamide

By  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 2, 2005-02 ,pp. : 233-236

Informa Healthcare

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors. Part 61. Quantum chemical QSAR of a group of benzenedisulfonamides

By Clare B.W.   Supuran C.T.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 6, 1999-06 ,pp. : 463-474

Elsevier

Access to resources Recommend Favorite